NCT03747861 is a NA clinical trial of SenceBand in HRV, sponsored by Planexta, Inc.

Who is sponsoring NCT03747861?

NCT03747861 is sponsored by Planexta, Inc.

What drugs are being tested in NCT03747861?

Interventions in NCT03747861: SenceBand.

Is NCT03747861 still recruiting?

NCT03747861 is currently completed. Last updated 18 February 2020.

Last reviewed 2020-02-18 · How we verify

NCT03747861

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measuring Accuracy of Wristband for Registration of ECG RR-Intervals for One Hand, SenceBand in Comparison to Holter

Completed NA Last updated 18 February 2020

What this trial tests

NA trial testing SenceBand in HRV in 59 participants. Completed in 24 January 2020.

Timeline

10 May 2019

Primary endpoint
24 January 2020

24 January 2020

Quick facts

Lead sponsor	Planexta, Inc
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	59
Start date	10 May 2019
Primary completion	24 January 2020
Estimated completion	24 January 2020
Sites	1 location across Ukraine

Drugs / interventions tested

SenceBand

Conditions studied

HRV — all drugs for HRV →

Sponsor

Planexta, Inc

Who can join

Adults 18 to 75, any sex, with HRV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to evaluate the measuring accuracy of the Wristband for registration of ECG RR intervals for one hand, SenceBand icompared to the Holter monitor (LabTech Ltd).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03747861 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Planexta, Inc
Last refreshed: 18 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03747861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing